Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Development of high-resolution melting analysis for the detection of the MYD88 L265P mutation.

Wang CZ, Lin J, Qian J, Shao R, Xue D, Qian W, Xiao GF, Deng ZQ, Yang J, Li Y, Chen XX.

Clin Biochem. 2013 Mar;46(4-5):385-7. doi: 10.1016/j.clinbiochem.2012.11.007. Epub 2012 Nov 21.

PMID:
23178471
2.

MYD88 expression and L265P mutation in diffuse large B-cell lymphoma.

Choi JW, Kim Y, Lee JH, Kim YS.

Hum Pathol. 2013 Jul;44(7):1375-81. doi: 10.1016/j.humpath.2012.10.026. Epub 2013 Feb 4.

PMID:
23380077
3.

Oncogenically active MYD88 mutations in human lymphoma.

Ngo VN, Young RM, Schmitz R, Jhavar S, Xiao W, Lim KH, Kohlhammer H, Xu W, Yang Y, Zhao H, Shaffer AL, Romesser P, Wright G, Powell J, Rosenwald A, Muller-Hermelink HK, Ott G, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Fisher RI, Braziel RM, Tubbs RR, Cook JR, Weisenburger DD, Chan WC, Staudt LM.

Nature. 2011 Feb 3;470(7332):115-9. doi: 10.1038/nature09671. Epub 2010 Dec 22.

PMID:
21179087
4.

Frequent MYD88 L265P and CD79B Mutations in Primary Breast Diffuse Large B-Cell Lymphoma.

Taniguchi K, Takata K, Chuang SS, Miyata-Takata T, Sato Y, Satou A, Hashimoto Y, Tamura M, Nagakita K, Ohnishi N, Noujima-Harada M, Tabata T, Kikuti YY, Maeda Y, Nakamura N, Tanimoto M, Yoshino T.

Am J Surg Pathol. 2016 Mar;40(3):324-34. doi: 10.1097/PAS.0000000000000592.

PMID:
26752547
5.

Rapid and reliable detection of IDH1 R132 mutations in acute myeloid leukemia using high-resolution melting curve analysis.

Lin J, Qian J, Yao DM, Li Y, Yang J, Chen Q, Chai HY, Xiao GF, Xu WR.

Clin Biochem. 2011 Jul;44(10-11):779-83. doi: 10.1016/j.clinbiochem.2011.04.014. Epub 2011 Apr 22.

PMID:
21539821
6.

High prevalence of the MYD88 mutation in testicular lymphoma: Immunohistochemical and genetic analyses.

Oishi N, Kondo T, Nakazawa T, Mochizuki K, Tanioka F, Oyama T, Yamamoto T, Iizuka J, Tanabe K, Shibata N, Kirito K, Katoh R.

Pathol Int. 2015 Oct;65(10):528-35. doi: 10.1111/pin.12336. Epub 2015 Aug 4.

PMID:
26388135
7.

Significance of MYD88 L265P Mutation Status in the Subclassification of Low-Grade B-Cell Lymphoma/Leukemia.

Insuasti-Beltran G, Gale JM, Wilson CS, Foucar K, Czuchlewski DR.

Arch Pathol Lab Med. 2015 Aug;139(8):1035-41. doi: 10.5858/arpa.2014-0322-OA.

PMID:
26230596
8.

MYD88 expression and L265P mutation in mature B-cell non-Hodgkin lymphomas.

Caner V, Sen Turk N, Baris IC, Cetin GO, Tepeli E, Hacioglu S, Sari I, Zencir S, Dogu MH, Bagci G, Keskin A.

Genet Test Mol Biomarkers. 2015 Jul;19(7):372-8. doi: 10.1089/gtmb.2015.0041. Epub 2015 May 15.

PMID:
25978699
9.

CD79B and MYD88 mutations in diffuse large B-cell lymphoma.

Kim Y, Ju H, Kim DH, Yoo HY, Kim SJ, Kim WS, Ko YH.

Hum Pathol. 2014 Mar;45(3):556-64. doi: 10.1016/j.humpath.2013.10.023. Epub 2013 Oct 31.

PMID:
24444466
10.

MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction.

Xu L, Hunter ZR, Yang G, Zhou Y, Cao Y, Liu X, Morra E, Trojani A, Greco A, Arcaini L, Varettoni M, Brown JR, Tai YT, Anderson KC, Munshi NC, Patterson CJ, Manning RJ, Tripsas CK, Lindeman NI, Treon SP.

Blood. 2013 Mar 14;121(11):2051-8. doi: 10.1182/blood-2012-09-454355. Epub 2013 Jan 15. Erratum in: Blood. 2013 Jun 27;121(26):5259. Varettoni, Maria [corrected to Varettoni, Marzia].

11.

Detection of MYD88 L265P mutation by real-time allele-specific oligonucleotide polymerase chain reaction.

Jiménez C, Chillón Mdel C, Balanzategui A, Puig N, Sebastián E, Alcoceba M, Sarasquete ME, Conde IP, Corral R, Marín LA, Paiva B, Ruano M, Antón A, Maldonado R, San Miguel JF, González M, García-Sanz R.

Appl Immunohistochem Mol Morphol. 2014 Nov-Dec;22(10):768-73. doi: 10.1097/PAI.0000000000000020.

PMID:
24992174
12.

MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.

Treon SP, Xu L, Yang G, Zhou Y, Liu X, Cao Y, Sheehy P, Manning RJ, Patterson CJ, Tripsas C, Arcaini L, Pinkus GS, Rodig SJ, Sohani AR, Harris NL, Laramie JM, Skifter DA, Lincoln SE, Hunter ZR.

N Engl J Med. 2012 Aug 30;367(9):826-33. doi: 10.1056/NEJMoa1200710.

13.

High frequency and clinical prognostic value of MYD88 L265P mutation in primary cutaneous diffuse large B-cell lymphoma, leg-type.

Pham-Ledard A, Beylot-Barry M, Barbe C, Leduc M, Petrella T, Vergier B, Martinez F, Cappellen D, Merlio JP, Grange F.

JAMA Dermatol. 2014 Nov;150(11):1173-9. doi: 10.1001/jamadermatol.2014.821.

PMID:
25055137
14.

MYD88 L265P mutation analysis helps define nodal lymphoplasmacytic lymphoma.

Hamadeh F, MacNamara SP, Aguilera NS, Swerdlow SH, Cook JR.

Mod Pathol. 2015 Apr;28(4):564-74. doi: 10.1038/modpathol.2014.120. Epub 2014 Sep 12.

15.

Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms.

Varettoni M, Arcaini L, Zibellini S, Boveri E, Rattotti S, Riboni R, Corso A, Orlandi E, Bonfichi M, Gotti M, Pascutto C, Mangiacavalli S, Croci G, Fiaccadori V, Morello L, Guerrera ML, Paulli M, Cazzola M.

Blood. 2013 Mar 28;121(13):2522-8. doi: 10.1182/blood-2012-09-457101. Epub 2013 Jan 25.

16.

Detection of MYD88 L265P mutations in formalin-fixed and decalcified BM biopsies from patients with lymphoplasmacytic lymphoma.

Capaldi IB, May AM, Schmitt-Graeff A, Follo M, Aumann K, Kayser G, Perazzo JC, Werner M, Fisch P.

Exp Mol Pathol. 2014 Aug;97(1):57-65. doi: 10.1016/j.yexmp.2014.05.005. Epub 2014 May 16.

PMID:
24842316
17.

MYD88 L265P and CXCR4 mutations in lymphoplasmacytic lymphoma identify cases with high disease activity.

Schmidt J, Federmann B, Schindler N, Steinhilber J, Bonzheim I, Fend F, Quintanilla-Martinez L.

Br J Haematol. 2015 Jun;169(6):795-803. doi: 10.1111/bjh.13361. Epub 2015 Mar 29.

PMID:
25819228
18.

MYD88 L265P mutation in Waldenstrom macroglobulinemia.

Poulain S, Roumier C, Decambron A, Renneville A, Herbaux C, Bertrand E, Tricot S, Daudignon A, Galiègue-Zouitina S, Soenen V, Theisen O, Grardel N, Nibourel O, Roche-Lestienne C, Quesnel B, Duthilleul P, Preudhomme C, Leleu X.

Blood. 2013 May 30;121(22):4504-11. doi: 10.1182/blood-2012-06-436329. Epub 2013 Mar 26.

19.

Consequences of the recurrent MYD88(L265P) somatic mutation for B cell tolerance.

Wang JQ, Jeelall YS, Beutler B, Horikawa K, Goodnow CC.

J Exp Med. 2014 Mar 10;211(3):413-26. doi: 10.1084/jem.20131424. Epub 2014 Feb 17.

20.

Allele-specific PCR is a powerful tool for the detection of the MYD88 L265P mutation in diffuse large B cell lymphoma and decalcified bone marrow samples.

Staiger AM, Ott MM, Parmentier S, Rosenwald A, Ott G, Horn H, Griese EU.

Br J Haematol. 2015 Oct;171(1):145-8. doi: 10.1111/bjh.13369. Epub 2015 Mar 30. No abstract available.

PMID:
25816840
Items per page

Supplemental Content

Write to the Help Desk